Wall St Engine
@wallstengine
Fast, accurate, consistent stock market news, earnings highlights & more. By Brillinsight. Not financial advice.
加入 March 2022
971 正在關注 196.1K 粉絲
FDA approves Eli Lilly’s $LLY Inluriyo + Verzenio for a form of advanced breast cancer driven by the ESR1 mutation.
The treatment is for adults with ER-positive, HER2-negative advanced or metastatic disease and is now available in the U.S.
顯示更多
